POPULARITY
15 episodes with md as
7 episodes with md as
2 episodes with md as
6 episodes with md as
2 episodes with md as
5 episodes with md as
2 episodes with md as
8 episodes with md as
4 episodes with md as
Host: Alexandria May, PharmD, BCPS Guest: Neil M. Iyengar, MD As first-line treatment options for metastatic triple-negative breast cancer continue to expand, emerging evidence and guideline updates are reshaping treatment selection. In this expert-led discussion, Dr. Alexandria May and Dr. Neil Iyengar review the growing role of biomarker-driven decision-making and examine how data from ASCENT-03, ASCENT-04, and TROPION-Breast02 are influencing preferred treatment approaches. Dr. Iyengar is the Director of the Cancer Survivorship Program and Co-Director of the Breast Medical Oncology Program at Winship Cancer Institute at Emory University.
Guest: Urs Weber, MD As outcomes improve for patients with ALK+ non-small cell lung cancer, attention is shifting toward therapies designed to push disease control even further. Tune in as Dr. Urs Weber examines promising agents in development and discusses the momentum driving the next phase of ALK-targeted treatment. Dr. Weber is an Assistant Professor in the Division of Medical Oncology at the University of Colorado Anschutz Medical Campus.
Guest: Jaime Imitola, MD As stem cell therapies continue to generate significant interest among patients with multiple sclerosis (MS), clinicians must be prepared to distinguish between approved treatments, investigational approaches, and unproven interventions marketed through stem cell tourism. Hear more as Dr. Jaime Imitola discusses the current landscape of stem cell therapies in MS, the risks associated with unregulated treatments, and the importance of patient education and evidence-based guidance. Dr. Imitola is the Vice Chair for Research of the Department of Neurology and the Director of the Division of Multiple Sclerosis and Translational Neuroimmunology at UConn Health. He also spoke about this topic at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting.
Guest: Jaime Imitola, MD As stem cell therapies continue to generate significant interest among patients with multiple sclerosis (MS), clinicians must be prepared to distinguish between approved treatments, investigational approaches, and unproven interventions marketed through stem cell tourism. Hear more as Dr. Jaime Imitola discusses the current landscape of stem cell therapies in MS, the risks associated with unregulated treatments, and the importance of patient education and evidence-based guidance. Dr. Imitola is the Vice Chair for Research of the Department of Neurology and the Director of the Division of Multiple Sclerosis and Translational Neuroimmunology at UConn Health. He also spoke about this topic at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting.
"Comments like this 'Oh, I didn't think you would continue in IR after having your baby,' don't help, because you're already going through a lot." -- Esha Kothekar, MD As part of the Kinked Wire podcast, medical student and SIR member Marie Hamel speaks with Esha Kothekar, MD, and Lei Yu, MD, the Women in Interventional Radiology Section vice chair, about the challenges that come with pregnancy as an interventional radiologist.SIR thanks Medtronic for its generous support of the Kinked Wire.Contact us with your ideas and questions, or read more about interventional radiology in IR Quarterly magazine or SIR's Patient Center. Senior Editorial Manager, Hope Racine, explains the work she does at SIR.Support the show
Interview avec Jérôme Bernard (directeur de la MDAS) et Caroline Josseaume (directrice de Alsace Mouvement Associatif) pour parler de leurs structures et des derniers chiffres du bénévolat en Alsace. Réalisé en direct sur RBS le 05/12/25 dans le créneau 14H-18H de Pierre LiermannÀ l'occasion de l'émission spéciale du Village du Partage (situé Place Kléber pendant le Marché de Noël) lors de la Journée Mondiale du Bénévolat
Mason Stevens' CIO Jacqui Fernley joins host James Whelan to explore the evolution of managed accounts and managed discretionary accounts for advisers. As market volatility rises and efficiency becomes paramount, managed accounts are increasingly valued for their ability to deliver scalable, tailored investment strategies—particularly for high-net-worth clients. Jacqui highlights emerging opportunities in private credit and thematic investments, while underscoring how managed accounts can simplify portfolio management, reduce client friction, and support consistent performance. Jacqueline Fernley LinkedIn: https://www.linkedin.com/in/jacqueline-fernley-cfa-cew-member-gaicd-2a8845b/ James Whelan LinkedIn: https://www.linkedin.com/in/james-whelan-68146036/ Interested in SMAs, MDAs, or model portfolios? Contact nick.mitchell@masonstevens.com.au or visit https://ensombl.com/go/20250811/ General Disclaimer – https://www.ensombl.com/disclaimer/
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Fudman, MD As the advanced treatment landscape for inflammatory bowel disease continues to expand, selecting the right therapies has become more complex, with efficacy, safety, patient preferences, disease phenotypes, and more as factors to consider. Learn how to effectively navigate these therapeutic options for ulcerative colitis and Crohn's disease with Dr. Peter Buch and Dr. David Fudman, Assistant Professor and Director of Inflammatory Bowel Disease Clinics at the University of Texas Southwestern Medical Center.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Fudman, MD As the advanced treatment landscape for inflammatory bowel disease continues to expand, selecting the right therapies has become more complex, with efficacy, safety, patient preferences, disease phenotypes, and more as factors to consider. Learn how to effectively navigate these therapeutic options for ulcerative colitis and Crohn's disease with Dr. Peter Buch and Dr. David Fudman, Assistant Professor and Director of Inflammatory Bowel Disease Clinics at the University of Texas Southwestern Medical Center.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: John Koo, MD As the array of novel therapies for plaque psoriasis expands, a strategy to navigate treatment options is to focus on the specific needs of different patient groups, like Medicare-aged patients. ILUMYA® (tildrakizumab-asmn) is the only biologic for plaque psoriasis guaranteed to be covered under the medical benefit of Medicare, with no prior authorization and zero cost as a likely possibility. Join Dr Charles Turck and Dr John Koo as they share insights on the efficacy, safety, and accessibility of ILUMYA in this patient population. Dr. Koo is a Professor of Dermatology at the University of California at San Francisco School of Medicine.
Guest: Jorge Nieva, MD As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.
Guest: Jorge Nieva, MD As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.
Guest: Jorge Nieva, MD As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care for patients with cancer. Learn more with Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.
Guest: Jorge Nieva, MD As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care for patients with cancer. Learn more with Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine.
《TECHIT, TECHIE》一個分享技術新知與科技應用的平臺，每一集都會送上當周國際間最夯的科技話題，並邀請尖端科技業者，聊聊他們的黑科技及實際應用。 包含AI、5G通訊應用、太空科技、綠色能源及電競Esports等，科技迷千萬不要錯過！ 立即收聽
Episode Topic: Generosity & Medicine with physicians Sneha Mantri, MD, MS and Abraham Nussbaum, MD As part of the Virtues & Vocations series Education for Flourishing: Conversations on Character & the Common Good, we are pleased to welcome Sneha Mantri, MD, MS, physician and director of Medical Humanities at Duke University School of Medicine, and Abraham Nussbaum, MD, physician, Chief Education Officer at Denver Health, and an author of several books, including the recently released Progress Notes. Mantri and Nussbaum wrote essays on generosity for the fall issue of the Virtues & Vocations magazine. Listen in on a discussion of their essays and others from the issue, American healthcare, and medical education.Featured Speakers:Suzanne Shanahan, Leo and Arlene Hawk Executive Director and Professor of the Practice at Notre Dame's Center for Social ConcernsSneha Mantri, MD, MS, physician and director of Medical Humanities at Duke University School of Medicine,Abraham Nussbaum, MD, physician, Chief Education Officer at Denver HealthRead this episode's recap over on the University of Notre Dame's open online learning community platform, ThinkND: https://go.nd.edu/92fe62.This podcast is a part of the ThinkND Series titled Virtues & Vocations. Thanks for listening! The ThinkND Podcast is brought to you by ThinkND, the University of Notre Dame's online learning community. We connect you with videos, podcasts, articles, courses, and other resources to inspire minds and spark conversations on topics that matter to you — everything from faith and politics, to science, technology, and your career. Learn more about ThinkND and register for upcoming live events at think.nd.edu. Join our LinkedIn community for updates, episode clips, and more.
Host: Jennifer Caudle, DO Guest: Lori Guyton, MD Guest: Douglas Scharre, MD As our understanding of Alzheimer's disease continues to evolve, it's critical to understand the clinical and pathologic changes underpinning Alzheimer's disease as it may be able to help guide early diagnosis and clinically meaningful management decisions.1 That's why Drs. Douglas Scharre and Lori Guyton speak with Dr. Jennifer Caudle about Alzheimer's disease pathophysiology and how it translates to clinical practice. Dr. Scharre is a Professor of Clinical Neurology and Psychiatry as well as the Director for the Division of Cognitive Neurology at the Ohio State University Wexner Medical Center in Columbus, and Dr. Guyton is a practicing neurologist with Neurology of Southern Illinois in Herrin. Reference: Porsteinsson A, Isaacson R, Knox S, Sabbagh M, Rubino I. Diagnosis of early Alzheimer's disease: Clinical practice in 2021. J Prev Alzheimers Dis. 2021;8:371-386. © Eisai Inc. 2024. All Rights Reserved.AD-M2130 November 2024
Host: Jennifer Caudle, DO Guest: Lori Guyton, MD Guest: Douglas Scharre, MD As our understanding of Alzheimer's disease continues to evolve, it's critical to understand the clinical and pathologic changes underpinning Alzheimer's disease as it may be able to help guide early diagnosis and clinically meaningful management decisions.1 That's why Drs. Douglas Scharre and Lori Guyton speak with Dr. Jennifer Caudle about Alzheimer's disease pathophysiology and how it translates to clinical practice. Dr. Scharre is a Professor of Clinical Neurology and Psychiatry as well as the Director for the Division of Cognitive Neurology at the Ohio State University Wexner Medical Center in Columbus, and Dr. Guyton is a practicing neurologist with Neurology of Southern Illinois in Herrin. Reference: Porsteinsson A, Isaacson R, Knox S, Sabbagh M, Rubino I. Diagnosis of early Alzheimer's disease: Clinical practice in 2021. J Prev Alzheimers Dis. 2021;8:371-386. © Eisai Inc. 2024. All Rights Reserved.AD-M2130 November 2024
Guest: John Brandsema, MD As patients with Duchenne muscular dystrophy (DMD) age, their treatment regimens, considerations, and goals change. That's why Dr. John Brandsema is here to talk about how we can best treat and support patients with DMD throughout their entire care journey. Dr. Brandsema is the Neuromuscular Section Head at the Children's Hospital of Philadelphia.
Guest: John F. Brandsema, MD As patients with Duchenne muscular dystrophy (DMD) age, their treatment regimens, considerations, and goals change. That's why Dr. John Brandsema is here to talk about how we can best treat and support patients with DMD throughout their entire care journey. Dr. Brandsema is the Neuromuscular Section Head at the Children's Hospital of Philadelphia.
In this classic episode I am talking to Dr Christopher Kerr about Death Bed Visions and his book 'Death is But a Dream: Hope and Meaning at Life's End'.In recent weeks, I've been thinking about a few standout episodes from the early days of the podcast. They are full of great information and I thought it would be a good idea to share them again for listeners who may have missed them the first time around. Christopher Kerr is a hospice doctor. All of his patients die. Yet he has cared for thousands of patients who, in the face of death, speak of love and grace. Beyond the physical realities of dying are unseen processes that are remarkably life-affirming. These include dreams that are unlike any regular dream. Described as "more real than real," these end-of-life experiences resurrect past relationships, meaningful events and themes of love and forgiveness; they restore life's meaning and mark the transition from distress to comfort and acceptance.Drawing on interviews with over 1,400 patients and more than a decade of quantified data, Dr. Kerr reveals that pre-death dreams and visions are extraordinary occurrences that humanize the dying process. He shares how his patients' stories point to death as not solely about the end of life, but as the final chapter of humanity's transcendence. Kerr's book also illuminates the benefits of these phenomena for the bereaved, who find solace in seeing their loved ones pass with a sense of calm closure.Beautifully written, with astonishing real-life characters and stories, this book is at its heart a celebration of our power to reclaim the dying process as a deeply meaningful one. Death Is But a Dream is an important contribution to our understanding of medicine's and humanity's greatest mystery.BioChristopher Kerr, MD, PhD, is the Chief Medical Officer and Chief Executive Officer forHospice & Palliative Care Buffalo. Born and raised in Toronto, Canada, Chris earned his MDas well as a PhD in Neurobiology. Dr. Kerr received numerous awards throughouttraining that recognized his clinical performance, as well as his success as an educator andscientist. Chris's background in research has evolved from bench science toward the humanexperience of illness as witnessed from the bedside, specifically patients' dreams and visionsat the end of life. Although medically ignored, these near-universal experiences often providecomfort and meaning, as well as insight into the life led and the death anticipated. To date,the research team at Hospice & Palliative Care Buffalo has published multiple studies on thistopic and documented over 1,500 end-of-life events, many of which are videotaped.This work was the subject of Chris's TEDx Buffalo Talk, which has been viewedapproximately 3 million times and has been the subject of reports on BBC and in The NewYork Times, The Washington Post, The Atlantic, Scientific American Mind, HuffingtonPost and Psychology Today. It will also be featured in an upcoming Netflix production and apublic television documentary film to be released nationally in early 2021. Dr. Kerr's workwas also published by Penguin Random House earlier this year in a book called Death Is Buta Dream, which is now being released in multiple languages.https://www.amazon.com/Death-But-Dream-Finding-Meaning-ebook/dp/B07SRQC373/ref=tmm_kin_swatch_0?_encoding=UTF8&qid=1613916946&sr=8-1https://www.drchristopherkerr.com/https://www.pastliveshypnosis.co.uk/https://www.patreon.com/ourparanormalafterlifeBecome a supporter of this podcast: https://www.spreaker.com/podcast/our-paranormal-afterlife-finding-proof-of-life-after-death--5220623/support.
Unleashed: The Political News Hour with Brian C Joondeph, MD – As the 2024 presidential election nears, polls suggest a tight race. Current Rasmussen and CNN polls show strong support for Trump over Biden, reflecting shifts in voter sentiment. Enthusiasm could play a key role, with Trump supporters showing higher excitement levels. Amidst a volatile economy and global tensions, it's crucial to stay informed and engaged.
Unleashed: The Political News Hour with Brian C Joondeph, MD – As the House slips closer toward Democrat control, this could spell the end of Donald Trump's reelection bid and push America closer to one-party totalitarian control, far from the Constitutional Republic we once knew. We are on a slippery slope, one we may not be able to recover from as a country if we continue our slide into one-party rule...
Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to unveil a groundbreaking development: the signing of a teaming agreement with a major international defense contractor. This strategic alliance is poised to propel maritime domain awareness to new heights by leveraging OPT's innovative Merrows suite of solutions. In his discussion with Proactive, Stratmann elucidated that the teaming agreement grants the international contractor exclusive rights to provide OPT's Maritime Domain Awareness Solution (MDAS) within specified geographic regions. This collaboration represents a fusion of OPT's cutting-edge technology with the contractor's unparalleled expertise in defense, homeland security, and commercial programs, aiming to fortify capabilities in maritime security and surveillance. At the heart of this collaboration lies MDAS, a revolutionary solution developed by OPT that integrates state-of-the-art data collection and analysis capabilities. By harnessing autonomous marine platforms such as vehicles and buoys, coupled with advanced sensors and data analytics, MDAS delivers comprehensive maritime surveillance, tracking, and monitoring capabilities. This real-time situational awareness empowers stakeholders across various sectors, including defense, environmental monitoring, and search and rescue operations. The partnership between OPT and the international defense contractor heralds a new era of innovation and collaboration in the realm of maritime domain awareness. By pooling their respective strengths and resources, the two entities are poised to enhance security and safety in key maritime regions, safeguarding vital interests and promoting stability in an ever-evolving global landscape. As OPT continues to push the boundaries of technological innovation, this partnership underscores the company's commitment to advancing maritime security and sustainability. Stay tuned for further updates as OPT and its collaborators pave the way for a safer and more secure maritime domain, empowered by cutting-edge solutions and strategic partnerships. #proactiveinvestors #oceanpowertechnologiesinc #nyseamerican #optt #OceanPowerTechnologies #PhilippStratmann #DefenceTechnology #MaritimeSecurity #ISR #AutonomousVehicles #MaritimeSurveillance #DataIntelligence #EnvironmentalMonitoring #TechInnovation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
In this captivating episode, Oluwakayode and Prof Erugo delve into strategies for alleviating the challenges faced by workers in Nigeria. They also explore the Federal Government's initiatives to streamline MDAs, aiming to reduce their number from 263 to 161 in line with the Orasonye report. Tune in as they analyze these plans and their potential impact on the Nigerian workforce.
Host: Tom Corbridge, MD, FCCP Guest: De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP Guest: Diego Maselli, MD Guest: Praveen Akuthota, MD As we continue to learn more about the underlying inflammatory pathways in asthma, we now have more novel tools and treatments to help us achieve control, remission, and better outcomes for our patients. But in order to achieve those goals, we must first detect severe asthma early enough to take full advantage of the latest advancements. Learn more about the importance of early detection and intervention in severe asthma care through the lens of a real-world patient case with Drs. Tom Corbridge, De De Gardner, Diego Maselli, and Praveen Akuthota. This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
Sju personer förlista på en ö. Sand och åter sand. Otrevliga leguaner smyger runt och vatten är en begränsad resurs. Det spills ut av misstag eller ren och skär ondska. Det dricks lite ojämnt. Fem män och två kvinnor är dödsdömda. ”De dömdas ö” kom ut 1946 och är Stig Dagermans andra roman. Enligt honom själv ”något av det mest märkliga jag har skrivit”. Finns en koppling till Hitchcock? Kan texter reta sina läsare? Vad gör ”De dömdas ö” så speciell? Lo och Bengt diskuterar.
Innovation has been a critical driver of progress in wealth management. As a result, various innovative investment strategies have emerged and been adopted. These vehicles offer customization, transparency, and flexibility, giving investors more control over their portfolios and aligning investments with their unique financial objectives. In this episode, Jack talks with a legend in wealthtech, Roger Paradiso, Global Head of Product Solutions at Franklin Templeton and Executive Chairman of O'Shaughnessy Asset Management. With every merger, acquisition, and sale in the past 30 years, Roger has seen problems and changes as opportunities. In 2014, Roger was bestowed the Money Management Institute's Advisory Solutions Pioneer Award, and in 2016, the All-Star Achiever Award. An advisory solutions industry leader with expertise in innovation, transformation, business enhancement, and strategy, Roger talks to Jack about how he created the concept of multiple-discipline accounts, commonly known as MDAs. Roger also shares how he moved the industry from mutual funds to separately managed accounts (SMAs) to multiple-discipline accounts (MDAs) to unified managed accounts (UMAs) and beyond. Key Takeaways [01:59] - Roger's impact in developing separately managed accounts (SMAs). [09:05] - The evolution of the multiple-discipline account (MDA). [13:08] - How Roger's multiple-discipline account gained significant traction. [19:15] - The transition from separately managed accounts to multi-discipline and unified managed accounts. [23:50] - The creation of unified managed accounts (UMAs). [29:01] - Franklin Templeton's efforts to fuel wealth management growth. [34:27] - Roger's take on the future of wealth management. [37:07] - Roger's three key takeaways from the conversation. [38:57] - Surprising facts about Roger. Quotes [05:11] - "I remember, at the time, all the information was on the one hard drive of one computer. The problem they had was because all this information was on one hard drive, all the information was incorrect over time. They were not getting good information in, and thus they had bad information going out." ~ Roger Paradiso [28:00] - "Franklin Templeton is now thinking about using technologies through acquisitions, deals, partnerships, or building ways we can continue to progress what the asset management industry looks like in the future." ~ Roger Paradiso [38:13] - "If you hire the smartest, brightest people around you in every job function, you're going to continue to win and support everyone because it's all about the people." ~ Roger Paradiso Links Roger Paradiso on LinkedIn Franklin Templeton O'Shaughnessy Asset Management Len Reinhart Jim Seuffert Salomon Brothers Citigroup Edward Jones Empower Canvas Connect with our hosts LifeYield Jack Sharry on LinkedIn Jack Sharry on Twitter Subscribe and stay in touch Apple Podcasts Spotify LinkedIn Twitter Facebook
Interview avec Théo de la MDAS réalisée au Village des associations, événement organisé par la Maison des Associations depuis plusieurs dizaines d'années. Diffusé dans Le 16-18 de Pierre Liermann le 11/09/23
Our Top 3 VideosHot take: CAR, LLC & JBHWhat's the attraction to MDAs?Two tech stocks poised to perform Hosted on Acast. See acast.com/privacy for more information.
Big Trouble in Little India! Indiana Jones råkar ut för nytt (gammalt) jävelskap i De fördömdas tempel. En rätt egendomlig uppföljare men vi gör vårt bästa i att försöka möta den halvvägs. Blir det nån Speed-referens? Jodå, var så säkra. James Bond då? Det med. Tintin? Ja ni, kan man hoppa fallskärm med en gummibåt? Exakt, dum fråga. På slutet hinner vi dessutom med att mumla lite osammanhängande inför Dial of Destiny som har premiär IDAG! WHAAAAAAT. Grattis till alla. Äej, nu åker vi. Mycket nöje! Notera att Robert sammanfattar filmen med ett pruttljud. OBS! Pga nån jävla skit är det emellanåt lite störningsljud i Linus mikrofon i början men det försvinner efter en stund. Hoppas ni kan ha överseende med detta. Stöd oss gärna via www.buymeacoffee.com/rebellradion
Today, Dr. Barr defines ‘skinny dipping' and shares her prescription to empower womxn to find comfort and confidence in their own skin.1. Why it's essential to look out for your skin2. Debunking the anti-aging myths3. Womxn's difficulties with stress management, creating boundaries, and reclaiming their voices4. How social constructs prevent womxn from embracing their own skin and body 5. The therapeutic power of somatic touch and accepting your flaws About Keira Barr, MDAs a mindfulness mentor and embodiment coach to visionary women leaders and entrepreneurs, a dual board-certified integrative dermatologist, global speaker, best-selling author, and host of The Skinny Dipping Rx podcast, Dr. Keira is empowering women around the world with the tools to help them feel more comfortable and confident in their skin.Blending science with soul, she shares her Skinny Dipping Methodology to further her mission of revolutionizing skin care as an act of radical self-care. Her work has been featured in MindBodyGreen, Better Homes and Gardens', Reader's Digest, Glamour, SELF, Oprah Magazine, and more.Connect with Keira Website: Resilient Health Institute Podcast: The Skinny Dipping Rx Instagram: @drkeirabarrSupport the show!Want to learn more about us? Visit our website at www.periodtopause.com or send an email to amanda@periodtopause.com.Follow us on Instagram: @periodtopauseFollow our Facebook Page: Period to Pause
Host: Matt Birnholz, MD Guest: Jonathan Corren, MD As recent research demonstrates the important role that TSLP plays in asthma inflammation, Dr Matt Birnholz is joined by Dr Jonathan Corren, an Associate Clinical Professor of Medicine and Pediatrics at David Geffen School of Medicine in Los Angeles. Together, they review how TSLP acts across the spectrum of asthma inflammation, the correlation of TSLP with clinical features of asthma, and more. ©2021 Amgen. All rights reserved. US-53813 Last Updated 6/21
Yearly, the Independent corrupt practices and other related offences, publishes it ethics and integrity compliance score card.This year, some major MDAs scored below average and some were declared non responsive and high corruption risk.In this episode of our Daily Podcasts, Nigeria Daily, we look at what this means for the Nigerian Justice system.
Host: Mario R. Nacinovich, Jr., MSc Guest: Richard Kojan, MD As the fight against Ebola continues, can a new biosecure emergency care unit (CUBE) and therapeutic guidelines from the World Health Organization (WHO) help combat this disease? Mario Nacinovich joins study Dr. Richard Kojan, President of the Alliance for International Medical Action, to discuss these new guidelines.
Host: Matt Birnholz, MD Guest: David Canaday, MD As we age, our immune system becomes weaker and is therefore unable to ward off infection as easily as in our younger years.1 This is particularly troublesome during flu season. In fact, the CDC's Advisory Committee on Immunization Practices (ACIP) recently looked at flu vaccine data for adults aged 65 years and older, and they now recommend that this age group preferentially receive higher dose or adjuvanted vaccines over standard dose unadjuvanted vaccines when available.2 So what was the data that led to these updated recommendations? Joining Dr. Matt Birnholz to share those key findings and the role of adjuvanted vaccines like FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) in preventing influenza in older adults is Dr. David Canaday, Professor in the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University in Cleveland. Avoid use in patients who have experienced any severe allergic reactions to any component of the vaccine. For more risk information please see below or consult the Full US Prescribing Information for FLUAD® QUADRIVALENT here. References:1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2(11):659-666.2. Centers for Disease Control and Prevention. Past seasons estimated influenza disease …
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael L. Weinstein, MD As clinicians, providing the best quality of care is paramount. But when it comes to procedure-intensive specialties, medical malpractice is a notable concern. So what do we need to know about the common malpractice claims in the GI field, and how can we mitigate the risk of those claims? To find out, Dr. Peter Buch is joined by Dr. Michael Weinstein, President and CEO of Capital Digestive Care.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael L. Weinstein, MD As clinicians, providing the best quality of care is paramount. But when it comes to procedure-intensive specialties, medical malpractice is a notable concern. So what do we need to know about the common malpractice claims in the GI field, and how can we mitigate the risk of those claims? To find out, Dr. Peter Buch is joined by Dr. Michael Weinstein, President and CEO of Capital Digestive Care.
Special episode alert! Kasama natin sa show si Doc Jerry Cua– doctor, vlogger, content creator, at head of the toCUA fam. Pinag-usapan namin ang kakaibang linya niya sa buhay: Kumusta nga ba ang buhay doktor, lalo sa mundo natin ngayon? Swabeng kwentuhan lang tungkol sa life inside and outside the MD: As one of the most demanding professions, how do you balance life? As one of the most recognized and respected professions, how do you remain grounded and empathetic? Paano nag-iiba ang larangan ng healthcare sa digital world na nag-uumapaw sa impormasyon? At sa panahon ngayon, paano nga ba natin mapagiginhawa ang mga sarili natin, physically, mentally, emotionally, para masabing #GinhawaIsLife? Basta for now, kinig muna tayo sa doctor's prescription: Listen up, yo! BOOM!
Special episode alert! Kasama natin sa show si Doc Jerry Cua– doctor, vlogger, content creator, at head of the toCUA fam. Pinag-usapan namin ang kakaibang linya niya sa buhay: Kumusta nga ba ang buhay doktor, lalo sa mundo natin ngayon? Swabeng kwentuhan lang tungkol sa life inside and outside the MD: As one of the most demanding professions, how do you balance life? As one of the most recognized and respected professions, how do you remain grounded and empathetic? Paano nag-iiba ang larangan ng healthcare sa digital world na nag-uumapaw sa impormasyon? At sa panahon ngayon, paano nga ba natin mapagiginhawa ang mga sarili natin, physically, mentally, emotionally, para masabing #GinhawaIsLife? Basta for now, kinig muna tayo sa doctor's prescription: Listen up, yo! BOOM!
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Lea Ann Chen, MD As clinicians, we know that adherence to treatment regimens is associated with improved outcomes in our patients with inflammatory bowel disease (IBD). However, many factors can contribute to a patient's nonadherence, and understanding what those factors are, especially in underserved patient populations, is an important category of care that we need to keep in mind. Tune in to hear Dr. Peter Buch speak with Dr. Lea Ann Chen about how we can manage IBD in underserved patient populations.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Lea Ann Chen, MD As clinicians, we know that adherence to treatment regimens is associated with improved outcomes in our patients with inflammatory bowel disease (IBD). However, many factors can contribute to a patient's nonadherence, and understanding what those factors are, especially in underserved patient populations, is an important category of care that we need to keep in mind. Tune in to hear Dr. Peter Buch speak with Dr. Lea Ann Chen about how we can manage IBD in underserved patient populations.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Steven W. Pipe, MD Guest: Giancarlo Castaman, MD As we continue to explore the role gene therapy may play in treating patients with hemophilia, what do we need to consider? Joining Dr. Charles Turck to share key lessons learned from implementing gene therapy in the clinical trial setting are Drs. Steven Pipe and Giancarlo Castaman.
Enabling economic growth and development through access to energy is at the heart of Em-One Energy Solutions' work. Since it was founded, Em-One has electrified rural healthcare centers and communities, government offices, schools, and much more.Mir S. Islam, CEO at Em-One, joins us this week to discuss their most recent project: a 1.5 MW / 2.28 MWh solar microgrid system with advanced microgrid control and grid integration for the Federal Government of Nigeria's Mabushi office block, also known as the Mabushi project.Recommended Reading FG partners firm to deploy micro-grid solutions for MDAs in AbujaEM-ONE is announced as one of the winners of the 2020 Canadian SDG Accelerator AwardsGuest Bio: Mir S. Islam grew up in Nigeria, and like many other Nigerians, he saw and experienced firsthand how lack of reliable power affects the lives of millions of people. He was motivated from a young age to play a role in improving outcomes and contributing to the betterment of the remote regions of Nigeria and worked in an electrification project providing energy access through grid extensions to over 300 towns across Nigeria, realizing then that grid extension could not solve the energy access challenge.Mir studied electrical engineering at the University of Nigeria, Nsukka, and traveled extensively across Nigeria to understand the challenges for communities and the public/private sector relating to the lack of electricity and water.Mir later moved to Canada to do his MBA at Schulich School of Business at York University and combined his understanding of engineering and technology with business and a focus on sustainability. His MBA shaped his understanding of how to expand energy access in Africa through sustainable technologies and that led to the founding of Em-One in 2009. Learn more about Em-One Energy Solutions Connect with Mir on LinkedInSupport the podcast on PatreonSubscribe to our newsletter
Host: Ana Maria Rosario Guest: Patricia M. Boatwright, MD As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn't always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.
Hellooooooo! Welcome back to The Series Review. Today, I will be reviewing The Mysterious Disappearance of Aidan S. (as told to his brother) by David Levithan. (The Mysterious Disappearance of Aidan S. (as told to his brother) will now be called MDAS (as told to his brother) because it takes so long to type all that.) This book follows a boy named Lucas, who is helping his family search for his brother, Aidan, who disappeared recently. Soon, Lucas finds Aidan in the attic of their house. Aidan says that he was in a magical world called Aveinieu, and he got there through a dresser! Lucas isn't sure what to believe. I love this book a lot. I read it in one day! It's a great mystery. Thanks for the support, listeners! If you have a book/series to recommend, email me at theseriesreview13@gmail.com. Enjoy the episode! Send me a voice message: https://anchor.fm/riya-b13/message
Happy Wednesday! Today we're talking to Megan Dorty, an ICF certified Narcissistic Abuse Recovery Coach, and she's giving us the low down on some new terms: "Love Bombing" and "Future Faking."Has someone told you very early on that they love you? Have they started painting a picture of marriage and kids and the white picket fence? Are you wondering what happened to that person who said those things because now you feel like you're dating Satan himself? WELL THIS EPISODE MIGHT BE FOR YOU!It's funny but it's not, right? This happens to so many of us! Megan is here to explain why and help you get over the narc in your life! Find Megan on Instagram: @love.bombed_mdAs always, we love you! Make sure to rate, review, subscribe and tell your friends! See you next week. We'd like to thank our partners this week:The Rescue Kit Company: For 10% off your purchase of any of their curated kits visit therescuekitco.com and use code: SAUCY10 at checkout. Follow @therescuekitcoVivi & Kay: For 20% off your buttery soft headband purchase visit etsy.com/shop/viviandkay and use code: SAUCY at check out. Follow @viviandkayThe Rescue Kit Company is proud to provide peace of mind with their simple, affordable, high-quality fashion emergency kits. Created by sisters, CEOs and seasoned stylists, The Bride Kit, The Closet Kit, and our Micro Kits are user-friendly, elegant, and cost-effective products curated specifically to prevent + solve any unexpected wardrobe mishaps that could arise.USE CODE SAUCY10 AT CHECK OUT
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host: Matthew Sorrentino, MD As the field of healthcare continues to change, how will the future of preventative cardiology be impacted? Join our Heart Matters hosts, Dr. Alan Brown and Dr. Mathew Sorrentino, as they sit down to discuss their experiences in preventative cardiology and the future of the healthcare system.
© 2020-2026 Ivy Podcast Discovery LLC
